US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Xenon Pharmaceuticals Inc.

< Previous 1 2 3 4 Next >
News headline image
Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual Novel Mechanisms in Neuropsychiatry Summit
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Announces Upcoming Investor Webinar with Leading Key Opinion Leaders to Discuss XEN1101 and Major Depressive Disorder
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at the Wells Fargo 2023 Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Expands Leadership on its Board of Directors with Appointments of Gillian M. Cannon and Justin Gover
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2023 Financial Results and Provide Corporate Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at the 2023 Jefferies Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at the 2023 RBC Capital Markets Global Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2023
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Corporate Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Showcases Its XEN1101 Epilepsy Program at the 2023 American Academy of Neurology (AAN) Annual Meeting
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at the Stifel 2023 CNS Days
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2022)
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Present at the Bank of America Securities Biotech SMID Cap Conference 2022
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Andrea DiFabio as Chief Legal Officer and Corporate Secretary
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Announces Launch of XEN1101 Phase 3 Program with Initiation of X-TOLE2 Clinical Trial in Patients with Focal Onset Seizures
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
News headline image
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
From Xenon Pharmaceuticals Inc.
Via GlobeNewswire
Tickers XENE
< Previous 1 2 3 4 Next >